Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.51 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.51 |
| ▸ | ITGAL | P20701 | 2/20 | 0.51 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | CNR1 | P21554 | 2/20 | 0.50 |
| ▸ | CNR2 | P34972 | 2/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 5/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.49 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.49 |
| ▸ | HRH2 | P25021 | 2/20 | 0.47 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10339074 | 0.99 | SLC6A5 (0.60) | SLC6A5CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL28830125 | 0.88 | SLC6A5 (0.61) | SLC6A5CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL18748761 | 0.88 | SLC6A5 (0.52) | SLC6A5CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL18748760 | 0.84 | SLC6A5 (0.53) | SLC6A5CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL15412861 | 0.84 | CPB2 (0.61) | SLC6A5CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL1666697 | 0.84 | ALDH1A1 (0.58) | SLC6A5CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL29152626 | 0.84 | QPCT (0.57) | SLC6A5CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL29152624 | 0.84 | QPCT (0.57) | SLC6A5CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL17204083 | 0.82 | SLC6A5 (0.87) | SLC6A5CYP3A4ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL15650015 | 0.82 | SLC6A5 (0.87) | SLC6A5CYP3A4ALDH1A1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2490709-B1 | PEPTIDIC GLP-2 AGONISTS | FERRING BV (NL) | 2014-11-26 | — | — | EP | disclosed |
| US-8580918-B2 | Peptidic GLP-2 agonists | FERRING B.V. (NL) | 2013-11-12 | — | — | US | disclosed |
| US-20120231999-A1 | PEPTIDIC GLP-2 AGONISTS | FERRING B.V. (NL) | 2012-09-13 | — | — | US | disclosed |
| EP-2314616-A1 | Peptidic GLP-2 agonists | Ferring B.V. (NL) | 2011-04-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120231999-A1 | PEPTIDIC GLP-2 AGONISTS | GLP1R, GIPR, IAPP | SLC6A5 1755/4885CYP3A4 3128/4885ALDH1A1 4333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.